Literature DB >> 26644805

Salvage therapies for prostate cancer: Keeping it in the mix.

Bryan J Donnelly1.   

Abstract

Entities:  

Year:  2015        PMID： 26644805      PMCID： PMC4662394          DOI： 10.5489/cuaj.3374

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  4 in total

1.  Radiotherapy and short-term androgen deprivation for localized prostate cancer.

Authors:  Christopher U Jones; Daniel Hunt; David G McGowan; Mahul B Amin; Michael P Chetner; Deborah W Bruner; Mark H Leibenhaut; Siraj M Husain; Marvin Rotman; Luis Souhami; Howard M Sandler; William U Shipley
Journal:  N Engl J Med       Date:  2011-07-14       Impact factor: 91.245

2.  Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications.

Authors:  J L Chin; S E Pautler; V Mouraviev; N Touma; K Moore; D B Downey
Journal:  J Urol       Date:  2001-06       Impact factor: 7.450

3.  Comparative morbidity of ablative energy-based salvage treatments for radio-recurrent prostate cancer.

Authors:  Khurram M Siddiqui; Michele Billia; Andrew Williams; Ali Alzahrani; Joseph L Chin
Journal:  Can Urol Assoc J       Date:  2015 Sep-Oct       Impact factor: 1.862

4.  Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes.

Authors:  Piyush K Agarwal; Natalia Sadetsky; Badrinath R Konety; Martin I Resnick; Peter R Carroll
Journal:  Cancer       Date:  2008-01-15       Impact factor: 6.860
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.